Assessment of Plaque Composition with Near-Infrared Spectroscopy

Current Cardiovascular Imaging Reports

Volumn 4, Issue 4, 2011, Pages 298-308

  Goldstein, James A ^a   Madden, Sean P ^a   Sum, Stephen T ^a   Dixon, Simon R ^a   Madder, Ryan D ^a   Muller, James E ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Acute myocardial infarction; Assessment of plaque composition with near infrared spectroscopy; Coronary atherosclerosis; Intravascular imaging; Spectroscopy; Vulnerable plaque

Indexed keywords

EID: 84873865059     PISSN: 19419066     EISSN: 19419074     Source Type: Journal    
DOI: 10.1007/s12410-011-9095-3     Document Type: Review

References (35)

1. Serruys PW, Morice M, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009; 360(10): 961-72.
2. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007; 356(15): 1503-16.
3. Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy. Circulation. 2008; 117(10): 1283-91.
4. •• Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, et al. PROSPECT Investigators. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011; 364(3): 226-35. This prospective study in humans identified vulnerable plaques employing IVUS with VH.
5. Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O'Neill WW. Multiple unstable plaques in patients with acute myocardial infarction. N Engl J Med. 2000; 343: 915-22.
6. •• Kolodgie FD, Burke AP, Farb A, Gold HK, Yuan J, Narula J, et al. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol. 2001; 16: 285-92. Pathologic description of TCFA, one of the key lesions felt to be a vulnerable plaque.
7. Heusch G, Kleinbongard P, Böse D, Levkau B, Haude M, Schulz R, et al. Coronary microembolization: from bedside to bench and back to bedside. Circulation. 2009; 120(18): 1822-36.
8. Yamagishi M, Terashima M, Awano K, Kijima M, Nakatani S, Daikoku S, et al. Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome. J Am Coll Cardiol. 2000; 35: 106-11.
9. Fujii K, Kobayashi Y, Mintz GS, Takebayashi H, Dangas G, Moussa L, et al. Intravascular ultrasound assessment of ulcerated ruptured plaques. A comparison of culprit and non-culprit lesions of patients with acute coronary syndromes and lesions in patients without acute coronary syndromes. Circulation. 2003; 108: 2473-8.
10. Hong MK, Mintz GS, Lee CW, Lee BK, Yang TH, Kim YH, et al. The Site of Plaque Rupture in Native Coronary Arteries: A Three-Vessel Intravascular Ultrasound Analysis. J Am Coll Cardiol. 2005; 46: 261-5.
11. Maehara A, Mintz GS, Weissman NJ. Advances in intravascular imaging. Circ Cardiovasc Interv. 2009; 5: 482-90.
12. • Thim T, Hagnesen MK, Wallace-Bradley D, Granada JF, Kaluza GL, Drouet L, et al. Unreliable assessment of necrotic core by virtual histology intravascular ultrasound in porcine coronary artery disease. Circ Cardiovasc Imaging. 2010; 3: 384-91. Histopathologic study suggesting limitations of IVUS-VH.
13. Jang IK, Tearney GJ, MacNeill B, Takano M, Moselewski F, Iftima N, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation. 2005; 111: 1551-5.
14. Kubo T, Imanishi T, Takarada S, et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol. 2007; 50: 933-9.
15. •• Gardner CM, Tan H, Hull EL, Lisauskas JB, Sum ST, Meese TM, et al. Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system. JACC Cardiovasc Imaging. 2008; 1(5): 638-48. Autopsy study validating accuracy of Lipiscan for detection of LCP.
16. •• Waxman S, Dixon SR, L'Allier P, Moses JW, Petersen JL, Cutlip D, et al. In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study. JACC Cardiovasc Imaging. 2009; 2(7): 858-68. Clinical study of Lipiscan catheter documenting spectral signals in humans similar to those validated by histopathologic proof of LCP.
17. • Schultz CJ, Serruys PW, van der Ent M, Ligthart J, Mastik F, Garg S, et al. First-in-man clinical use of combined near-infrared spectroscopy and intravascular ultrasound: a potential key to predict distal embolization and no-reflow? J Am Coll Cardiol. 2010; 56(4): 314. First use of combined multimodality NIRS-IVUS catheter in humans.
18. Madden SP, Sum ST, Muller JE. Assessment of Plaque Composition with Near Infrared Spectroscopy. In: Escaned J, Serruys PW, editors. Coronary Artery Stenosis: Imaging, Structure and Physiology. Toulouse, France: Europa Edition, 2010. p. 245-61.
19. Sum S, Madden S, Hendricks M, Chartier S, Muller J. Near-infrared spectroscopy for the detection of lipid core coronary plaques. Curr Cardiovasc Imaging Rep. 2009; 2(4): 307-15.
20. •• Goldstein JA, Grines C, Fischell T, Virmani R, Rizik D, Muller J, et al. Coronary embolization following balloon dilation of lipid-core plaques. JACC Cardiovasc Imaging. 2009; 2(12): 1420-4. "Connecting the dots" between LCP and distal embolization complications.
21. Mauri L, Rogers C, Baim DS. Devices for distal protection during percutaneous coronary revascularization. Circulation. 2006; 113(22): 2651-6.
22. •• Prasad A, Singh M, Lerman A, Lennon RJ, Holmes DR Jr, Rihal CS. Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality. J Am Coll Cardiol. 2006; 48(9): 1765-70. Clinical implications of periprocedural MI.
23. • Selvanayagam JB, Porto I, Channon K, Petersen SE, Francis JM, Neubauer S, et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation. 2005; 111(8): 1027-32. Myocardial injury due to periprocedural MI.
24. Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard AD, Satler LF, et al. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: intravascular ultrasound study of 2256 patients. Circulation. 2000; 101(6): 604-10.
25. Hong YJ, Mintz GS, Kim SW, Lee SY, Okabe T, Pichard AD, et al. Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: an ultrasound analysis. JACC Cardiovasc Imaging. 2009; 2(4): 458-68.
26. • Kotani J, Nanto S, Mintz GS, Kitakaze M, Ohara T, Morozumi T, et al. Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation. 2002; 106(13): 1672-7. Distal embolization of lipid contents leading to "no-reflow".
27. Kawamoto T, Okura H, Koyama Y, Toda I, Taguchi H, Tamita K, et al. The relationship between coronary plaque characteristics and small embolic particles during coronary stent implantation. J Am Coll Cardiol. 2007; 50(17): 1635-40.
28. Uetani T, Amano T, Ando H, Yokoi K, Arai K, Kato M, et al. The correlation between lipid volume in the target lesion, measured by integrated backscatter intravascular ultrasound, and post-procedural myocardial infarction in patients with elective stent implantation. Eur Heart J. 2008; 29(14): 1714-20.
29. Maini B, Brilakis ES, Kim M, Hendricks MJ, Madden SP, Sum ST, et al. Association of large lipid core plaque detected by near infrared spectroscopy with post percutaneous coronary intervention myocardial infarction. J Am Coll Cardiol. 2010; 55; A179. E1672.
30. • Liu X, Tsujita K, Maehara A, Mintz GS, Weisz G, Dangas GD, et al. Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug-eluting stent implantation. JACC Cardiovasc Interv. 2009; 2(10): 997-1004. Potential benefits of IVUS to guide optimal stenting.
31. Oemrawsingh PV, Mintz GS, Schalij MJ, et al. Intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenoses: final results of a randomized comparison with angiographic guidance (TULIP Study). Circulation. 2003; 107(1): 62-7.
32. Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol. 2011; 57(11): 1314-22.
33. Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS, et al. Pathology of acute and chronic coronary stenting in humans. Circulation. 1999; 99(1): 44-52.
34. • Sakhuja R, Suh WM, Jaffer FA, Jang IK. Residual Thrombogenic Substrate After Rupture of a Lipid-Rich Plaque: Possible Mechanism of Acute Stent Thrombosis? Circulation. 2010; 122(22): 2349-50. Potential risk of subacute stent thrombosis due to uncovered LCP.
35. Waxman S, Freilich MI, Suter MJ, Shishkov M, Bilazarian S, Virmani R, et al. A case of lipid core plaque progression and rupture at the edge of a coronary stent: elucidating the mechanisms of drug-eluting stent failure. Circ Cardiovasc Interv. 2010; 3(2): 193-6.